2025-521535-36-00RecruitingPhase 1
A Phase 1 study of JNJ-95437446 in participants with advanced-stage solid tumors
Source: EU CTIS (euclinicaltrials.eu) · Last updated 8 Jun 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- First submitted
- 16 Jul 2025
- Start date
- 3 Nov 2025
- Lead sponsor
- Janssen Cilag International
- Diseases
- Lung cancer
- EU CT number
- 2025-521535-36-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 52
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Recruiting |
| Hospital Universitario HM Sanchinarro | Madrid | Spain | Recruiting |
| Hospital Universitario 12 de Octubre | Madrid | Spain | Recruiting |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.